Modulation by polymyxin B of the effects of interferon on human myelogenous leukemia cells.
Natural and recombinant human interferon-alpha (IFN-alpha) and -gamma (IFN-gamma) exert differentiation-inducing and cytocidal effects in vitro on cells of the human myeloblastic leukemia cell line ML-2. These activities of IFNs are modulated by polymyxin B (PMB), a cyclic polycationic peptide antibiotic effective on Gram-negative bacilli. The modulating effect of PMB varies according to the species of IFN, namely, PMB enhances the activities of either natural IFN-gamma or recombinant IFN-gamma, while it inhibits the effects of either natural IFN-alpha or recombinant IFN-alpha. The cause of this variety in PMB effect on IFNs remains to be clarified.